1. Home
  2. JSPRW vs FISI Comparison

JSPRW vs FISI Comparison

Compare JSPRW & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPRW
  • FISI
  • Stock Information
  • Founded
  • JSPRW N/A
  • FISI 1817
  • Country
  • JSPRW United States
  • FISI United States
  • Employees
  • JSPRW N/A
  • FISI N/A
  • Industry
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • FISI Major Banks
  • Sector
  • JSPRW Health Care
  • FISI Finance
  • Exchange
  • JSPRW Nasdaq
  • FISI Nasdaq
  • Market Cap
  • JSPRW N/A
  • FISI N/A
  • IPO Year
  • JSPRW N/A
  • FISI 1999
  • Fundamental
  • Price
  • JSPRW $0.12
  • FISI $28.66
  • Analyst Decision
  • JSPRW
  • FISI Buy
  • Analyst Count
  • JSPRW 0
  • FISI 4
  • Target Price
  • JSPRW N/A
  • FISI $29.75
  • AVG Volume (30 Days)
  • JSPRW 7.8K
  • FISI 160.5K
  • Earning Date
  • JSPRW 03-05-2025
  • FISI 01-30-2025
  • Dividend Yield
  • JSPRW N/A
  • FISI 4.33%
  • EPS Growth
  • JSPRW N/A
  • FISI N/A
  • EPS
  • JSPRW N/A
  • FISI N/A
  • Revenue
  • JSPRW N/A
  • FISI $110,758,000.00
  • Revenue This Year
  • JSPRW N/A
  • FISI N/A
  • Revenue Next Year
  • JSPRW N/A
  • FISI $7.80
  • P/E Ratio
  • JSPRW N/A
  • FISI N/A
  • Revenue Growth
  • JSPRW N/A
  • FISI N/A
  • 52 Week Low
  • JSPRW $0.15
  • FISI $16.29
  • 52 Week High
  • JSPRW $0.16
  • FISI $29.79
  • Technical
  • Relative Strength Index (RSI)
  • JSPRW N/A
  • FISI 56.91
  • Support Level
  • JSPRW N/A
  • FISI $27.22
  • Resistance Level
  • JSPRW N/A
  • FISI $29.79
  • Average True Range (ATR)
  • JSPRW 0.00
  • FISI 0.76
  • MACD
  • JSPRW 0.00
  • FISI 0.12
  • Stochastic Oscillator
  • JSPRW 0.00
  • FISI 66.96

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: